Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study

Published:2017-06 Issue:6 Volume:69 Page:374-381
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Izzo Joseph L.,Zappe Dion H.,Jia Yan,Hafeez Kudsia,Zhang Jack

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference17 articles.

1. Clinical advisory statement. Importance of systolic blood pressure in older Americans;Izzo;Hypertension,2000

2. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008;Egan;JAMA,2010

3. Plasma norepinephrine and age as determinants of systemic hemodynamics in men with established essential hypertension;Izzo;Hypertension,1987

4. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension;Weidmann;Kidney Int.,1978

5. Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results;Izzo;J Clin Hypertens.,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension;JACC: Asia;2024-09

2. Efficacy of sacubitril/valsartan versus valsartan in patients with arterial hypertension;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2024-02-05

3. Antihypertensive Effects of Sacubitril/Valsartan Versus Olmesartan: An Updated Systemic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2023-11-12

4. Experience of sacubitril/valsartan therapy in hypertension;Cardiovascular Therapy and Prevention;2023-09-05

5. Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study;Journal of the American Heart Association;2023-04-18